Wie können wir helfen?
Final analysis of a randomised trial comparing pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory advanced melanoma
You do not have access to this post.
1445534
{:LPR5HH3Z}
1
https://www.zotero.org/styles/urban-research-and-practice?source=1
50
default
1
1
145
http://www.hautkrebs-leitlinien.de/wp-content/plugins/zotpress/